A Study of Ivonescimab in People With Non-Small Cell Lung Cancer

NCT07594522 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

RADIATION: Photon or Proton standard stereotactic body radiotherapy (SBRT)
DRUG: Ivonescimab

Sponsor

Memorial Sloan Kettering Cancer Center